文献速递消化道肿瘤放疗放疗物理与技术

直肠癌常规分割放疗小肠剂量体积与急性毒性系统综述与荟萃分析

Systematic review and meta-analysis of small bowel dose-volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy.
PubMed 文献 · Radiother Oncol · 2019-05-25

三项研究(203例)的固定效应荟萃分析显示,发生≥3级毒性患者的小肠V5Gy至V40Gy均显著更高(p<0.00001);逻辑回归中V10Gy对毒性风险的预测最强(p=0.004)。

要点

  • ≥3级毒性患者小肠V5Gy至V40Gy均显著高于无毒性患者
  • 绝对差异在最低剂量体积参数最大,相对差异随剂量升高而增大
  • V5Gy、V10Gy、V30Gy至V45Gy可预测毒性风险,其中V10Gy预测最强

核心结论

  • 已发表的临床队列剂量体积数据支持直肠癌放疗中小肠存在剂量体积与毒性反应关系,低剂量与高剂量参数均可预测急性毒性风险。

研究设计与样本

  • 对可获取均值绝对体积及参数误差指标的数据,采用固定效应逆方差荟萃分析按≥3级毒性分组比较。
  • 其余数据采用非参数方法考察受照小肠剂量体积与毒性发生率,并拟合单变量逻辑回归模型。

主要发现

  • 三项研究(203例)固定效应荟萃分析显示,≥3级毒性患者V5Gy至V40Gy各剂量体积指标均显著大于无≥3级毒性患者(p<0.00001)。
  • 绝对差异在最低剂量体积参数最大,相对差异随剂量增加而增大。
  • 逻辑回归中V5Gy、V10Gy、V30Gy至V45Gy多个小肠DVH参数可预测毒性风险,V10Gy预测最强(p=0.004)。

关键数值与推荐

  • 荟萃分析纳入3项研究、共203例患者。
  • V5Gy至V40Gy在≥3级毒性组与无≥3级毒性组间差异的p<0.00001。
  • 逻辑回归中V10Gy预测毒性风险最强,p=0.004。

临床怎么用

  • 直肠癌常规分割放疗计划时应同时关注小肠低剂量与高剂量体积参数以评估急性毒性风险。
  • 剂量提升探索中可将小肠剂量体积参数作为毒性风险参考,但需结合原文数据谨慎解读。

局限性

  • 仅3项研究(203例)具备均值绝对体积与参数误差指标,可纳入固定效应荟萃分析。
  • 其余数据采用非参数考察与单变量逻辑回归,证据强度有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The limited radiation tolerance of the small-bowel causes toxicity for patients receiving conventionally-fractionated radiotherapy for rectal cancer. Safe radiotherapy dose-escalation will require a better understanding of such toxicity. We conducted a systematic review and meta-analysis using published datasets of small bowel dose-volume and outcomes to analyse the relationship with acute toxicity. MATERIALS AND METHODS: SCOPUS, EMBASE & MEDLINE were searched to identify twelve publications reporting small-bowel dose-volumes and toxicity data or analysis. Where suitable data were available (mean absolute volume with parametric error measures), fixed-effects inverse-variance meta-analysis was used to compare cohorts of patients according to Grade ≥3 toxicity. For other data, non-parametric examinations of irradiated small-bowel dose-volume and incidence of toxicity were conducted, and a univariate logistic regression model was fitted. RESULTS: On fixed-effects meta-analysis of three studies (203 patients), each of the dose-volume measures V5Gy-V40Gy were significantly greater (p < 0.00001) for patients with Grade ≥3 toxicity than for those without. Absolute difference was largest for the lowest dose-volume parameter; however relative difference increases with increasing dose. On logistic regression multiple small-bowel DVH parameters were predictive of toxicity risk (V5Gy, V10Gy, V30Gy - V45Gy), with V10Gy the strongest (p = 0.004). CONCLUSIONS: Analysis of published clinical cohort dose-volume data provides evidence for a significant dose-volume-toxicity response effect for a wide range of clinically-relevant doses in the treatment of rectal cancer. Both low dose and high dose are shown to predict toxicity risk, which has important implications for radiotherapy planning and consideration of dose escalation for these patients.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Holyoake DLP, Partridge M, Hawkins MA, et al. Systematic review and meta-analysis of small bowel dose-volume and acute toxicity in conventionally-fractionated rectal cancer radiotherapy. Radiother Oncol. 2019. PMID: 31136961. doi:10.1016/j.radonc.2019.05.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。